Expression of constitutively active IκBβ in T cells of transgenic mice: Persistent NF-κB activity is required for T-cell immune responses

Molecular and Cellular Biology

Volumn 18, Issue 1, 1998, Pages 477-487

  Attar, Ricardo M ^a   Macdonald Bravo, Heather ^a   Raventos Suarez, Carmen ^a   Durham, Stephen K ^a   Bravo, Rodrigo ^a  

^a BRISTOL MYERS SQUIBB   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PHYTOHEMAGGLUTININ; TRANSCRIPTION FACTOR;

ANIMAL CELL; ARTICLE; CELLULAR IMMUNITY; DNA BINDING; GENE EXPRESSION; MOUSE; MUTATION; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; TRANSGENIC MOUSE;

ANIMALIA; MUS MUSCULUS;

EID: 0031982966     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/mcb.18.1.477     Document Type: Article

References (77)

1. Albertella, M. R., and R. D. Campbell. 1994. Characterization of a novel gene in the human major histocompatibility complex that encodes a potential new member of the IkB family of proteins. Hum. Mol. Genet. 3:793-799.
2. Alkalay, I. A. Yaron, A. Hatzubai, S. Jung, A. Avraham, O. Gerlitz, I. Pashut-Lavon, and Y. Ben-Neriah. 1995. In vivo stimulation of IκB phosphorylation is not sufficient to activate NF-κB. Mol. Cell. Biol. 15:1294-1301.
3. Allen, J. M., K. A. Forbush, and R. M. Perlmutter. 1992. Functional dissection of the lck proximal promoter. Mol. Cell. Biol. 12:2758-2768.
4. Baeuerle, P. A., and T. Henkel. 1994. Function and activation of NF-κB in the immune system. Annu. Rev. Immunol. 12:141-179.
5. Baldi, L., K. Brown, G. Franzoso, and U. Siebenlist. 1996. Critical role for lysines 21 and 22 in signal-induced, ubiquitin-mediated proteolysis of IkBa. J. Biol. Chem. 271:376-379.
6. Baldwin, A. S. 1996. The NF-κB and IκB proteins, new discoveries and insights. Annu. Rev. Immunol. 14:649-681.
7. Beg, A. A., and A. S. Baldwin, Jr. 1993. The IκB proteins: multifunctional regulators of Rel/NF-κB transcription factors. Genes Dev. 7:2064-2070.
8. Beg, A. A., and D. Baltimore. 1996. An essential role for NF-κB in preventing TNF-α-induced cell death. Science 274:782-784.
9. Beg, A. A., W. C. Sha, R. T. Bronson, and D. Baltimore. 1995. Constitutive NF-κB activation, enhanced granulopoiesis, and neonatal lethality in IκBα-deficient mice. Genes Dev. 9:2736-2746.
10. Beg, A. A., W. C. Sha, R. T. Bronson, S. Ghosh, and D. Baltimore. 1995. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB. Nature 376:167-169.
11. Boothby, M. R., A. L. Mora, D. C. Scherer, J. A. Brockman, and D. W. Ballard. 1997. Perturbation of the T lymphocyte lineage in transgenic mice expressing a constitutive repressor of nuclear factor (NF)-κB. J. Exp. Med. 185:1897-1907.
12. Bours, V., G. Franzoso, V. Azarenko, S. Park, T. Kanno, K. Brown, and U. Siebenlist. 1993. The oncoprotein Bcl-3 directly transactivates through κB motifs via association with DNA-binding p50B homodimers. Cell 72:729-739.
13. Brockman, J. A., D. C. Scherer, T. A. McKinsey, S. M. Hall, X. Qi, W. Y. Lee, and D. W. Ballard. 1995. Coupling of a signal response domain in IκBα to multiple pathways for NF-κB activation. Mol. Cell. Biol. 15:2809-2818.
14. Brown, K., S. Gerstberger, L. Carlson, G. Franzoso, and U. Siebenlist. 1995. Control of IκBα proteolysis by site-specific, signal-induced phosphorylation. Science 267:1485-1488.
15. Caamano, J. H., P. Perez, S. A. Lira, and R. Bravo. 1996. Constitutive expression of Bcl-3 in thymocytes increases the DNA binding of NF-κB (p50) homodimers in vivo. Mol. Cell. Biol. 16:1342-1348.
16. Capobianco, A. J., D. Chang, G. Mosialos, and T. D. Gilmore. 1992. p105, the NF-κB p50 precursor protein, is one of the cellular proteins complexed with the v-Rel oncoprotein in transformed chicken spleen cells. J. Virol. 66:3758-3767.
17. Carrasco, D., C. A. Rizzo, K. Dorfman, and R. Bravo. 1996. The v-rel oncogene promotes malignant T-cell leukemia/lymphoma in transgenic mice. EMBO J. 15:3640-3650.
18. Chase, M. W. 1967. Production of antiserum. Methods Immunol. Immunochem. 1:197-209.
19. Chen, Z., J. Hagler, V. J. Palombella, F. Melandri, D. Scherer, D. Ballard, and T. Maniatis. 1995. Signal-induced site-specific phosphorylation targets IκBα to the ubiquitin-proteasome pathway. Genes Dev. 9:1586-1597.
20. Chen, Z. J., L. Parent, and T. Maniatis. 1996. Site-specific phosphorylation of the IκBα by a novel ubiquitination-dependent protein kinase activity. Cell 84:853-862.
21. Coligan, J. E., A. M. Kruisbeek, D. H. Margulies, E. M. Shevach, and W. Strober. 1992. Isolation and fractionation of mononuclear cell populations, p. 3.1.1-3.1.5. In J. W. Sons (ed.), Current protocols in immunology. Greene Publishing Associates & Wiley-Interscience, New York, N.Y.
22. Coligan, J. E., A. M. Kruisbeek, D. H. Margulies, E. M. Shevach, and W. Strover. 1992. In vivo assays for mouse lymphocyte function, p. 4.2.1-4.2.5. In J. W. Sons (ed.), Current protocols in immunology. Greene Publishing Associates & Wiley-Interscience, New York, N.Y.
23. DiDonato, J., F. Mercurio, C. Rosette, J. Wu-Li, H. Suyang, S. Ghosh, and M. Karin. 1996. Mapping of the inducible IκB phosphorylation sites that signal its ubiquitination and degradation. Mol. Cell. Biol. 16:1295-1304.
24. Didonato, J. A., M. Hayakawa, D. M. Rothwarf, E. Zandi, and M. Karin. 1997. A cytokine-responsive IκB kinase that activates the transcription factor NF-κB. Nature 388:548-554.
25. Dobrzanski, P., R.-P. Ryseck, and R. Bravo. 1993. Both N-and C-terminal domains of RelB are required for full transactivation: role of the N-terminal leucine zipper-like motif. Mol. Cell. Biol. 13:1572-1582.
26. Dobrzanski, P., R.-P. Ryseck, and R. Bravo. 1995. Specific inhibition of RelB/p52 transcriptional activity by the C-terminal domain of p100. Oncogene 10:1003-1007.
27. Esslinger, C. W., A. Wilson, B. Sordat, F. Beermann, and V. Jongeneel. 1997. Abnormal T lymphocyte development induced by targeted overexpression of I-kappa-B-alpha. J. Immunol. 158:5075-5078.
28. Finco, T. S., and A. S. Baldwin. 1995. Mechanistic aspects of NF-κB regulation: the emerging role of phosphorylation and proteolysis. Immunity 3: 263-272.
29. Fujita, T., G. P. Nolan, H.-C. Liou, M. L. Scott, and D. Baltimore. 1993. The candidate proto-oncogene bcl-3 encodes a transcriptional coactivator that activates through NF-κB p50 homodimers. Genes Dev. 7:1354-1363.
30. Gilmore, T. D., and P. J. Morin. 1993. The IκB proteins: members of a multifunctional family. Trends Genet. 9:427-433.
31. Grilli, M., J.-S. Chiu, and M. J. Lenardo. 1993. NF-κB and Rel - participants in a multiform transcriptional regulatory system. Int. Rev. Cytol. 143. 1-62.
32. Harhaj, E. W., S. B. Maggirwar, L. Good, and S.-C. Sun. 1996. CD28 mediates a potent costimulatory signal for rapid degradation of IκBβ which is associated with accelerated activation of various NF-κB/Rel heterodimers. Mol. Cell. Biol. 16:6736-6743.
33. Haskill, S., A. A. Beg, S. M. Tompkins, J. S. Morris, A. D. Yurochko, A. Sampson-Johanne, K. Mondal, P. Ralph, and A. S. Baldwin. 1991. Characterization of an immediate early gene induced in adherent monocytes that encodes IκB-like activity. Cell 65:1281-1289.
34. Inoue, J.-I., L. D. Kerr, A. Kakizuka, and I. M. Verma. 1992. IκBγ, a 70 kd protein identical to the C-terminal half of p110 NF-κB: a new member of the IκB family. Cell 68:1109-1120.
35. Klement, J. F., N. R. Rice, B. D. Car, S. J. Abbondanzo, G. D. Powers, H. Bhatt, C.-H. Chen, C. A. Rosen, and C. L. Stewart. 1996. IκBα deficiency results in a sustained NF-κB response and severe widespread dermatitis in mice. Mol. Cell. Biol. 16:2341-2349.
36. Köntgen, F., R. J. Grumont, A. Strasser, D. Metcalf, R. Li, D. Tarlinton, and S. Gerondakis. 1995. Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression. Genes Dev. 9:1965-1977.
37. Kopp, E. B., and S. Ghosh. 1995. NF-κB and Rel proteins in innate immunity. Adv. Immunol. 58:1-27.
38. 1 transition in mouse fibroblasts: in vitro and in vivo associations. Mol. Cell. Biol. 11:2451-2459.
39. Kunkel, T. A., J. D. Roberts, and R. A. Zakour. 1987. Rapid and efficient site-specific mutagenesis without phenotypic selection. Methods Enzymol. 154:367-382.
40. + B cells from antibody-secreting and memory B cell pathways in the C57BL/6 immune response to NP. Eur. J. Immunol. 22:3001-3011.
41. Lang, G., C. Mamalaki, D. Greenberg, N. Yannoutsos, and D. Kioussis. 1991. Deletion analysis of the human CD2 gene locus control region in transgenic mice. Nucleic Acids Res. 19:5851-5856.
42. Lernbecher, T., U. Müller, and T. Wirth. 1993. Distinct NF-κB/Rel transcription factors are responsible for tissue-specific and inducible gene activation. Nature 365:767-770.
43. Lewis, D. B., C. C. Yu, K. A. Forbush, J. Carpenter, T. A. Sato, A. Grossman, D. H. Liggitt, and R. M. Perlmutter. 1991. Interleukin 4 expressed in situ selectively alters thymocyte development. J. Exp. Med. 173:89-100.
44. Liou, H.-C., and D. Baltimore. 1993. Regulation of the NF-κB/rel transcription factor and κB inhibitor system. Curr. Opin. Cell Biol. 5:477-487.
45. McKinsey, T. A., J. A. Brockman, D. C. Scherer, S. W. Al-Murrani, P. L. Green, and D. W. Ballard. 1996. Inactivation of IκBβ by the Tax protein of human T-cell leukemia virus type 1: a potential mechanism for constitutive induction of NF-κB. Mol. Cell. Biol. 16:2083-2090.
46. Mercurio, F., J. A. DiDonato, C. Rosette, and M. Karin. 1993. p105 and p98 precursor proteins play an active role in NF-κB-mediated signal transduction. Genes Dev. 7:705-718.
47. Miyamoto, S., and I. M. Verma. 1995. Rel/NF-κB story. Adv. Cancer Res. 66:255-292.
48. Muller, H. K., C. Bucana, and M. L. Kripke. 1992. Antigen presentation in the skin: modulation by u.v. radiation and chemical carcinogens. Semin. Immunol. 4:205-215.
49. Naumann, M., A. Nieters, E. N. Hatada, and H. C. Scheidereit. 1993. NF-κB precursor p100 inhibits nuclear translocation and DNA binding of NF-κB/ rel-factors. Oncogene 8:2275-2281.
50. Naumann, M., F. G. Wulczyn, and C. Scheidereit. 1993. The NF-κB precursor p105 and the proto-oncogene product Bcl-3 are IκB molecules and control nuclear translocation of NF-κB. EMBO J. 12:213-222.
51. Nolan, G. P., K. Fujita, K. Bhatia, C. Huppi, H.-C. Lio, M. L. Scott, and D. Baltimore. 1993. The bcl-3 proto-oncogene encodes a nuclear IκB-like molecule that preferentially interacts with NF-κB p50 and p52 in a phosphorylation-dependent manner. Mol. Cell. Biol. 13:3557-3566.
52. Perez, P., S. A. Lira, and R. Bravo. 1995. Overexpression of RelA in transgenic mouse thymocytes: specific increase on levels of the inhibitor IκBα. Mol. Cell. Biol. 15:3523-3530.
53. Ray, P., D.-H. Zhang, J. A. Elias, and A. Ray. 1995. Cloning of a differentially expressed IκB-related protein. J. Biol. Chem. 270:10680-10685.
54. Régnier, C. H., H. Y. Song, X. Gao, D. V. Goeddel, Z. Cao, and M. Rothe. 1997. Identification and characterization of an IκB kinase. Cell 90:373-383.
55. Rice, N. R., M. L. MacKichan, and A. Israel. 1992. The precursor of NF-κB p50 has IκB-like functions. Cell 71:243-253.
56. Scheinman, R. I., A. A. Beg, and A. S. J. Baldwin. 1993. NF-κB p100 (Lyt-10) is a component of H2TF1 and can function as an IκB-like molecule. Mol. Cell. Biol. 13:6089-6101.
57. Scherer, D. C., J. A. Brockman, Z. Chen, T. Maniatis, and D. W. Ballard. 1995. Signal-induced degradation of IκBα requires site-specific ubiquitination. Proc. Natl. Acad. Sci. USA 92:11259-11263.
58. Schreiber, E., P. Matthias, M. M. Muller, and W. Schaffner. 1989. Rapid detection of octamer hinding proteins with "mini-extracts," prepared from a small number of cells. Nucleic Acids Res. 17:6419.
59. Scott, M. L., T. Fujita, H.-C. Liou, G. P. Nolan, and D. Baltimore. 1993. The p65 subunit of NF-κB regulates IκB by two distinct mechanisms. Genes Dev. 7:1266-1276.
60. Sha, W. C., H.-C. Liou, E. I. Tuomanen, and D. Baltimore. 1995. Targeted disruption of the p50 subunit of NF-κB leads to multifocal defects in immune responses. Cell 80:321-330.
61. Siebenlist, U., G. Franzoso, and K. Brown. 1994. Structure, regulation, and function of NF-κB. Annu. Rev. Cell Biol. 10:405-455.
62. Singh, H., R. Sen, D. Baltimore, and P. A. Sharp. 1986. A nuclear factor that binds to a conserved sequence motif in transcriptional control elements of immunoglobulin genes. Nature 319:154-158.
63. Son, S.-C., P. A. Ganchi, C. Beraud, D. W. Ballard, and W. C. Greene. 1994. Autoregulation of the NF-κB transactivator RelA (p65) by multiple cytoplasmic inhibitors containing ankyrin motifs. Proc. Natl. Acad. Sci. USA 91:1346-1350.
64. Sun, S. C., J. Elwood, and W. C. Greene. 1996. Both amino-and carboxy-terminal sequences within IκBα regulate its inducible differentiation. Mol. Cell. Biol. 16:1058-1065.
65. Suyang, H., R. Phillips, I. Douglas, and S. Ghosh. 1996. Role of unphosphorylated, newly synthesized IκBβ in persistent activation of NF-κB. Mol. Cell. Biol. 16:5444-5449.
66. Thanos, D., and T. Maniatis. 1995. NF-κB: a lesson in family values. Cell 80:529-532.
67. Thompson, J. E., R. J. Phillips, H. Erdjument-Bromage, P. Tempst, and S. Ghosh. 1995. IκBβ regulates the persistent response in a biphasic activation of NF-κB. Cell 80:573-582.
68. Traenckner, E. B.-T., H. L. Pahl, T. Henkel, K. N. Schmidt, S. Wilk, and P. A. Baeuerle. 1995. Phosphorylation of human IκBα on serines 32 and 36 controls IκBα proteolysis and NF-κB activation in response to diverse stimuli. EMBO J. 14:2876-2883.
69. Van Antwerp, D. J., S. J. Martin, T. Kafri, D. R. Green, and I. M. Verma. 1996. Suppression of TNF-α-induced apoptosis by NF-κB. Science 274:787-789.
70. Verma, I. M., J. K. Stevenson, E. M. Schwarz, D. Van Antwerp, and S. Miyamoto. 1995. Rel/NF-κB/IκB family: intimate tales of association and dissociation. Genes Dev. 9:2723-2735.
71. Wang, C.-Y., M. W. Mayo, and A. S. Baldwin, Jr. 1996. TNF-and cancer therapy-induced apoptosis: potentiation hy inhibition of NF-κB. Science 274:784-787.
72. Weih, F., D. Carrasco, S. K. Durham, D. S. Barton, C. A. Rizzo, R.-P. Ryseck, S. A. Lira, and R. Bravo. 1995. Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of RelB, a member of the NF-κB/Rel family. Cell 80:331-340.
73. Weih, F., S. A. Lira, and R. Bravo. 1996. Overexpression of RelB in transgenic mice does not affect IκBα levels: differential regulation of RelA and RelB by the inhibitor protein. Oncogene 12:445-459.
74. Weih, F., R.-P. Ryseck, L. Chen, and R. Bravo. 1996. Apoptosis of nur77/ N10-transgenic thymocytes involves the Fas/Fas ligand pathway. Proc. Natl. Acad. Sci. USA 93:5533-5538.
75. Whiteside, S. T., J.-C. Epinat, N. R. Rice, and A. Israël. 1997. I kappa B epsilon, a novel member of the IκB family, controls RelA and cRel NF-κB activity. EMBO J. 16:1413-1426.
76. Whiteside, S. T., M. K. Ernst, O. LeBail, C. Laurent-Winter, N. Rice, and A. Israel. 1995. N-and C-terminal sequences control degradation of MAD3/ IκBα in response to inducers of NF-κB activity. Mol. Cell. Biol. 15:5339-5345.
77. Wulczyn, F. G., M. Naumann, and C. Scheidereit. 1992. Candidate protooncogene bcl-3 encodes a subunit-specific inhibitor of transcription factor NF-κB. Nature 358:597-599.